FierceBiotech2h
Journey of Voyager’s ALS gene therapy to clinic hindered by need to find alternative payload
The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...
Neurology Advisor2h
Real-World Study Suggests Fewer ALS Progression Milestones With Edaravone
A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.
FierceBiotech12d
2 hormone therapies restore normal sleep in mouse models of amyotrophic lateral sclerosis
Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...
Science Daily3d
ALS survival may be cut short by living in disadvantaged communities
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...
ALS News Today1d
US trial of noninvasive ALS device gets green light to enroll patients
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
Nature4y
First licensed stem cell therapy for ALS
Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...